Clinical trial NCT00798850 - References

Intermittent Claudication — Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease

Citation(s)

•   Barletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Brevetti G
  Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med. 1996;1(1):3-7.
•   Chan YC, Shukla N, Abdus-Samee M, Berwanger CS, Stanford J, Singh M, Mansfield AO, Stansby G
  Anti-heat-shock protein 70 kDa antibodies in vascular patients. Eur J Vasc Endovasc Surg. 1999 Nov;18(5):381-5.
•   Chetter IC, Spark JI, Dolan P, Scott DJ, Kester RC
  Quality of life analysis in patients with lower limb ischaemia: suggestions for European standardisation. Eur J Vasc Endovasc Surg. 1997 Jun;13(6):597-604.
•   Chetter IC, Spark JI, Kent PJ, Berridge DC, Scott DJ, Kester RC
  Percutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicine. Eur J Vasc Endovasc Surg. 1998 Dec;16(6):477-84.
•   Davies A
  The practical management of claudication. BMJ. 2000 Oct 14;321(7266):911-2.
•   Ernst E
  Exercise: the best therapy for intermittent claudication? Br J Hosp Med. 1992 Sep 16-Oct 6;48(6):303-4, 307. Review.
•   Fowkes FG, Gillespie IN
  Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev. 2000;(2):CD000017. Review. Update in: Cochrane Database Syst Rev. 2018 Mar 09;3:CD000017.
•   Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ
  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991 Jun;20(2):384-92.
•   Gallino A, Mahler F, Probst P, Nachbur B
  Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation. 1984 Oct;70(4):619-23.
•   Gardner AW, Poehlman ET
  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995 Sep 27;274(12):975-80.
•   Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT
  The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993 May 29;306(6890):1440-4.
•   Gelin J, Jivegård L, Taft C, Karlsson J, Sullivan M, Dahllöf AG, Sandström R, Arfvidsson B, Lundholm K
  Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements. Eur J Vasc Endovasc Surg. 2001 Aug;22(2):107-13.
•   Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, Ruckley CV
  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996 Dec;25(6):1172-81.
•   Mazari FA, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T, McCollum PT, Chetter IC
  An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femorop
•   Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, Chetter IC
  Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg. 2010 Jan;24(1):69-79. doi:
•   Mazari FA, Khan JA, Carradice D, Samuel N, Abdul Rahman MN, Gulati S, Lee HL, Mehta TA, McCollum PT, Chetter IC
  Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication d
•   Mazari FA, Khan JA, Carradice D, Samuel N, Gohil R, McCollum PT, Chetter IC
  Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disea
•   Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M
  Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg. 1997 Feb;25(2):312-8; discussion 318-9.
•   Phillips MJ, Cowan AR, Johnson CD
  Intermittent claudication should not be treated by surgery. Ann R Coll Surg Engl. 1997 Jul;79(4):264-7.
•   Pockley AG, Bulmer J, Hanks BM, Wright BH
  Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones. 1999 Mar;4(1):29-35.
•   Pockley AG, Shepherd J, Corton JM
  Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest. 1998 Dec;27(6):367-77.
•   Powers SK, LOCKE And M, Demirel HA
  Exercise, heat shock proteins, and myocardial protection from I-R injury. Med Sci Sports Exerc. 2001 Mar;33(3):386-92. Review.
•   Roma P, Catapano AL
  Stress proteins and atherosclerosis. Atherosclerosis. 1996 Dec 20;127(2):147-54. Review.
•   Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN
  Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 Sep;26(3):517-38. Erratum in: J Vasc Surg 2001 Apr;33(4):805.
•   Smith GD, Shipley MJ, Rose G
  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation. 1990 Dec;82(6):1925-31.
•   Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP
  Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg. 1997 Nov;14(5):344-50.
•   van der Heijden FH, Eikelboom BC, Banga JD, Mali WP
  Management of superficial femoral artery occlusive disease. Br J Surg. 1993 Aug;80(8):959-63. Review.
•   Whitley D, Goldberg SP, Jordan WD
  Heat shock proteins: a review of the molecular chaperones. J Vasc Surg. 1999 Apr;29(4):748-51. Review.
•   Wick G
  Atherosclerosis--an autoimmune disease due to an immune reaction against heat-shock protein 60. Herz. 2000 Mar;25(2):87-90. Review.
•   Xu Q, Kiechl S, Mayr M, Metzler B, Egger G, Oberhollenzer F, Willeit J, Wick G
  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study. Circulation. 1999 Sep 14;100(11):1169-74.
•   Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, Epstein SE
  Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation. 2001 Feb 27;103(8):1071-5.

Randomised Controlled Trial of Percutaneous Transluminal Angioplasty (PTA) Versus a Supervised Exercise Programme (SEP) in the Management of Intermittent Claudication (IC) Due to Femoro-popliteal Disease

Details for clinical trial NCT00798850